1-16 of 16
Hans Loibner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ralph A. Reisfeld, PhD: In Memoriam (1926–2020)

James P. Allison, Edward Barker, Jürgen C. Becker, Thomas F. Bumol, David Cheresh, Bill Church, Soldano Ferrone, Darrell R. Galloway, Martin Giedlin, Stephen Gillies, Rupert Handgretinger, John R. Harper, Kohzoh Imai, Barry Kahan, Ruth Ladenstein, Debbie Liao, Holger N. Lode, Hans Loibner, Yun-Ping Luo, Barbara M. Mueller, AhKau Ng, Andreas Niethammer, Michele Pellegrino, Ursula Pertl, Vito Quaranta, Carlo Russo, Helen Sabzevari, Martin Schrappe, Gregor Schulz, Paul Sondel, Andreas Stahl, Argyrios Theophilopoulos, Nissi Varki, Leslie Walker, Barry Wilson, Wolfgang Wrasidlo, Ursula Wargalla-Plate, Rong Xiang, Alice Yu, He Zhou
Journal: Cancer Research
Cancer Res (2021) 81 (6): 1429–1430.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-0450
Published: 15 March 2021
View article
PDF
Journal Articles

Abstract CT410: Immune activation, clinical response and survival following long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in high-risk neuroblastoma patients

Holger Lode, Christian Jensen, Nikolai Siebert, Silke Kietz, Karoline Ehlert, Ina Müller, Ruth Ladenstein, Evelyne Janzek, Hans Loibner
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT410.
DOI: https://doi.org/10.1158/1538-7445.AM2014-CT410
Published: 01 October 2014
View article
Journal Articles

Abstract 2858: Binding characteristics of the immunocytokine hu14.18-IL2 and induction of human effector functions as anticipated mode of action.

Hans Loibner, Manfred Schuster, Evelyne Janzek, Stefan Stranner, Bernhard Peball, Susanne Wiederkum, Oliver Mutschlechner, Nikolai Siebert, Holger Lode
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2858.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2858
Published: 15 April 2013
View article
Journal Articles

Abstract 868: Oral SHP-1 inhibitor TPI-1a4 increases TILs in melanoma tumors and interacts positively with CTLA4 antibody for melanoma cure in mice

Taolin Yi, Daniel Lindner, Ralph Tuthill, Hans Loibner, Ernest Borden
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 868.
DOI: https://doi.org/10.1158/1538-7445.AM2012-868
Published: 15 April 2012
View article
Journal Articles

Abstract #LB-157: Exploratory analysis of gender and age aspects in a finished placebo-controlled randomized trial with the cancer vaccine IGN101 in 762 NSCLC patients in the adjuvant setting

Hans Loibner, Franz Groiss, Erich Stoelben
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-157.
Published: 01 May 2009
View article
Journal Articles

Abstract #5661: Development of an effective cancer immune therapy by Cbl-b silencing

Guenther Lametschwandtner, Gottfried Baier, Thomas Gruber, Sabine Gruenaug, Manfred Schuster, Hans Loibner
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5661.
Published: 01 May 2009
View article
Journal Articles

Development of recombinant human soluble angiotensin converting enzyme 2 (rhACE2) for cancer therapy

Hans Loibner, Evelyne Janzek, Bernhard Peball, Manfred Schuster
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4075.
Published: 01 May 2008
View article
Journal Articles

Humoral immune response to linear EpCAM-peptides induced by the mimotope cancer vaccine IGN101: Assessment by two independent methods

Astrid Durauer, Hans Loibner, Manfred Schuster, Thomas Bauernhofer, Hellmut Samonigg, Alois Jungbauer
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1856.
Published: 01 May 2007
View article
Journal Articles

Low lymphocyte counts at baseline of stage IV cancer patients treated with the cancer vaccine IGN101 predict prolonged survival : A retrospective analysis of a double-blind placebo controlled Phase II study

Hans Loibner
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-362.
Published: 01 May 2007
View article
Journal Articles

Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Manfred Schuster, Pablo Umana, Claudia Ferrara, Peter Brünker, Christian Gerdes, Günter Waxenecker, Susanne Wiederkum, Cornelia Schwager, Hans Loibner, Gottfried Himmler, Geert C. Mudde
Journal: Cancer Research
Cancer Res (2005) 65 (17): 7934–7941.
DOI: https://doi.org/10.1158/0008-5472.CAN-04-4212
Published: 01 September 2005
View article
PDF
Journal Articles

Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells: correlation with cytokine release

Ralf Kircheis, Andreas Nechansky, Petra Vondru, Susanne Grunt, Irene Zinöcker, Gottfried Himmler, Hans Loibner, Geert C. Mudde
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1218.
Published: 01 May 2005
View article
Journal Articles

Immunization of Rhesus monkeys with a multi-epitope vaccine IGN402 induces immune responses against EpCAM and SialylTn carbohydrate antigen

Ralf Kircheis, Petra Vondru, Irene Zinoecker, Daniela Haering, David Krey, Andreas Nechansky, Guenter Waxenecker, Geert C. Mudde, Gottfried Himmler, Hans Loibner
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1259.
Published: 01 April 2004
View article
Journal Articles

IGN312: Increased effector functions of a monoclonal antibody by glycoform engineering.

Manfred Schuster, Pablo Umana, Peter Brünker, Gottfried Himmler, Geert Mudde, Irmgard Froihofer, Susanne Wiederkum, Cornelia Schwager, Helga Klug, Hans Loibner
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 879–880.
Published: 01 April 2004
View article
Journal Articles

Oriented EpCAM presentation improves detection of anti EpCAM antibodies

Andreas Nechansky, Susanne Grunt, Irmgard Froihofer, Oliver Scheiber, Susanne Wiederkum, Oliver Szolar, Cornelia Schwager, Helga Klug, Hans Loibner, Gottfried Himmler, Erich Wasserbauer, Alois Jungbauer, Astrid Duerauer, Manfred Schuster, Geert Mudde
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1059–1060.
Published: 01 April 2004
View article
Journal Articles

Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors

Markus Klinger, Hesso Farhan, Herwig Just, Helmut Drobny, Gottfried Himmler, Hans Loibner, Geert C. Mudde, Michael Freissmuth, Veronika Sexl
Journal: Cancer Research
Cancer Res (2004) 64 (3): 1087–1093.
DOI: https://doi.org/10.1158/0008-5472.CAN-03-2435
Published: 10 February 2004
View article
PDF
Journal Articles

Humanized Anti-Lewis Y Antibodies: In Vitro Properties and Pharmacokinetics in Rhesus Monkeys

Man Sung Co, Jeanne Baker, K. Bednarik, E. Janzek, W. Neruda, P. Mayer, R. Plot, B. Stumper, Max Vasquez, Cary Queen, Hans Loibner
Journal: Cancer Research
Cancer Res (1996) 56 (5): 1118–1125.
Published: 01 March 1996
View article
PDF